|
2025
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations for injection; pharmaceutical preparatio... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations for
injection; pharmaceutical preparati... |
|
2024
|
Invention
|
Lipid depot formulations.
The present invention relates to pre-formulations comprising low visco... |
|
|
Invention
|
Opioid formulations. A depot precursor formulation comprising: a) a controlled-release matrix; b)... |
|
|
G/S
|
Business administrative services for medical referrals for treatment of genetic, metabolic, endoc... |
|
|
Invention
|
Controlled release peptide formulations.
The present invention relates to compositions forming a... |
|
|
Invention
|
Compositions and methods for treating acromegaly. This disclosure provides compositions and metho... |
|
|
Invention
|
Injectable buprenorphine formulation. c) at least 16% by weight of at least one active agent sele... |
|
2023
|
Invention
|
Treprostinil formulations. This disclosure provides treprostinil compositions and its use thereof. |
|
|
Invention
|
Opioid formulations.
A depot precursor formulation comprising: a) a controlled-release matrix; b... |
|
|
Invention
|
Somatostatin receptor agonist formulations.
The present invention relates to compositions formin... |
|
|
Invention
|
Mixtures and formulations.
The present invention relates to mixtures comprising:
... |
|
2022
|
G/S
|
Pharmaceutical preparations and substances for the treatment of genetic, metabolic, endocrine, ca... |
|
|
Invention
|
Prostacyclin analogue formulations.
The present invention relates to an injectable pre-formulati... |
|
|
G/S
|
Pharmaceutical preparations for injection for the treatment of Polycystic Kidney Disease (PKD); p... |
|
|
G/S
|
Pharmaceutical preparations for injection for the treatment of endocrine diseases and disorders; ... |
|
|
Invention
|
Compositions and methods for treating neuroendocrine tumors.
This disclosure provides compositio... |
|
|
Invention
|
Compositions and methods for treating neuroendocrine tumors. This disclosure provides composition... |
|
|
Invention
|
Mixtures and formulations. wherein the pre-formulation has a water content in the range of 0 to 1... |
|
2021
|
Invention
|
Formulations containing a somatostatin receptor agonist.
wherein the pre-formulation has a water... |
|
|
G/S
|
Pharmaceutical and veterinary preparations; sanitary
preparations for medical purposes; dietetic... |
|
|
Invention
|
Injectable buprenorphine formulation. The present invention provides an injectable liquid formula... |
|
|
Invention
|
Peptide slow-release formulations.
A composition for the delayed delivery of a peptide active ag... |
|
|
Invention
|
Opioid formulations. c) at least 12% by weight of at least one active agent selected from bupreno... |
|
|
Invention
|
Opioid formulations. A depot precursor formulation comprising:
a) a controlled-release matrix;
... |
|
2020
|
Invention
|
Formulations and treatment methods.
A lipid controlled-release formulation comprising: a) about ... |
|
|
Invention
|
Formulations and treatment methods. A lipid controlled-release formulation comprising: a) about 3... |
|
|
Invention
|
Controlled-release formulations.
The present invention relates to pre-formulations comprising lo... |
|
|
Invention
|
Formulations containing a somatostatin receptor agonist. wherein the pre-formulation has a water ... |
|
|
Invention
|
Lipid-controlled release compositions. The disclosure provides a glass syringe or a glass cartrid... |
|
|
Invention
|
Administration device & regime. Described herein are injection devices suitable for lipid control... |
|
|
Invention
|
Opioid formulations.
A depot precursor formulation comprising:
a) a controlled-release matr... |
|
|
Invention
|
Opioid formulations. c) at least 12% by weigh of at least one active agent selected from buprenor... |
|
2019
|
Invention
|
Compositions. The present invention relates to compositions comprising: (a) a biodegradable polym... |
|
|
G/S
|
Pharmaceutical and veterinary preparations; Sanitary preparations for medical purposes; Dietetic ... |
|
2018
|
G/S
|
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic ... |
|
|
G/S
|
Devices for subcutaneous administration of drugs sold empty; injection devices for parenteral adm... |
|
|
G/S
|
Devices for subcutaneous administration of drugs; devices
for parenteral administration of drugs... |
|
|
G/S
|
Devices, namely, injection instruments with needles and injection instruments without needles for... |
|
|
Invention
|
Lipid formulations comprising a thiolated antioxidant.
The present invention provides a formulat... |
|
|
G/S
|
Pharmaceutical preparations, namely, for the treatment of substance use disorders, substance depe... |
|
2017
|
Invention
|
Acid containing lipid formulations.
The present invention relates to compositions forming a low ... |
|
|
Invention
|
Mixtures and formulations comprising an alkyl ammonium edta salt. The present invention relates t... |
|
|
Invention
|
Formulations containing a somatostatin receptor agonist. The present invention relates to pre-for... |
|
|
G/S
|
Chemical laboratories; chemical research, chemical analysis; research and development in the fiel... |
|
|
G/S
|
Bleaching preparations and other substances for laundry use;
cleaning, polishing, scouring and a... |
|
|
G/S
|
Bleaching preparations for laundry use; substances for laundry use, namely, starch, detergent and... |
|
|
Invention
|
Prostacyclin analogue formulations. The present invention relates to an injectable pre-formulatio... |
|
|
G/S
|
Pharmaceutical preparations for internal use only and for
the treatment of drug addicted patient... |
|
|
Invention
|
Gnrh analogue formulations.
The present invention relates to compositions forming a low viscosit... |
|
|
G/S
|
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and ab... |
|
|
G/S
|
Pharmaceutical preparations for internal use only and for the treatment of drug addicted patients... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of chemical addictions; injectable pharmaceuticals ... |
|
2016
|
Invention
|
Controlled-release formulations.
The present invention relates to an injectable pre-formulation ... |
|
|
Invention
|
Controlled-release formulations. The present invention relates to an injectable pre-formulation c... |
|
2015
|
Invention
|
Controlled-release formulations. The present invention relates to pre-formulations comprising low... |
|
|
Invention
|
Injectable buprenorphine formulation.
The present invention provides an injectable liquid formul... |
|
|
G/S
|
Soaps; Perfumery, essential oils, cosmetics, hair lotions; Dentifrices; Cosmetic skin care produc... |
